Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-003461
Filing Date
2023-01-12
Accepted
2023-01-12 17:00:38
Documents
1
Period of Report
2023-01-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm233200-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm233200-3_4seq1.xml 4 5270
  Complete submission text file 0001104659-23-003461.txt   6705
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Hudson Frederick M. (Reporting) CIK: 0001438462 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 23526497